SCHEMBL16503530

SCHEMBL16503530

COC(=O)/C=C/CC(O[Si](C)(C)C(C)(C)C)/C(C)=C/c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.34
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RAB9A P51151 2/20 0.33
BACE1 P56817 1/20 0.33
NPC1 O15118 1/20 0.33
NR1H4 Q96RI1 1/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 2/20 0.32
TSHR P16473 1/20 0.32
AKR1C3 P42330 1/20 0.32
BTN3A1 O00481 1/20 0.32
LMNA P02545 1/20 0.32
IP6K1 Q92551 1/20 0.32
IP6K3 Q96PC2 1/20 0.32
IP6K2 Q9UHH9 1/20 0.32
GRIK1 P39086 1/20 0.32
GRIK2 Q13002 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16503520 0.79 KMT2A (0.39) KMT2AKDM4ESMN1; SMN2RAB9ABACE1
SCHEMBL16503524 0.78 POLB (0.35) KMT2AKDM4ESMN1; SMN2RAB9ABACE1
SCHEMBL16503528 0.75 TSHR (0.39) RECQLKMT2AMEN1ALDH1A1TSHR
SCHEMBL16503521 0.71 POLB (0.33) KMT2AKDM4ERAB9ANPC1NR1H4
SCHEMBL16503532 0.70 CCNC (0.38) KMT2AKDM4ESMN1; SMN2MEN1MTNR1A
SCHEMBL16503525 0.70 CYP26A1 (0.34) RAB9ANR1H4POLBAKR1C3
SCHEMBL16900479 0.69 NPSR1 (0.39) RECQLKMT2AKDM4ESMN1; SMN2RAB9A
SCHEMBL4135244 0.68 HDAC3 (0.38) KDM4EBACE1ALDH1A1
SCHEMBL4135249 0.68 HDAC3 (0.38) KDM4EBACE1ALDH1A1
SCHEMBL16503531 0.68 CA2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403842-B1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2016-06-29 EP disclosed
US-9079869-B2 Chiral disulfonimides STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-07-14 US disclosed
US-9079869-B2 Chiral disulfonimides STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-07-14 US disclosed
US-20110313150-A1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-12-22 US disclosed
US-20110313150-A1 CHIRAL DISULFONIMIDES STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313150-A1 CHIRAL DISULFONIMIDES STS, SUDS3, SF1 RECQL 886/4885KMT2A 3397/4885KDM4E 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.